Tessier P, Ghezzo H, L'Archevêque J, Cartier A, Malo J L
Department of Chest Medicine, Hôpital du Sacré-Coeur, Montreal, Canada.
Am Rev Respir Dis. 1987 Dec;136(6):1418-23. doi: 10.1164/ajrccm/136.6.1418.
Inhalation of cold air at increasing levels of minute ventilation with assessment of bronchomotor tone between each inhalation (dose-response curve) has been used as a method to assess bronchial hyperresponsiveness. However, no information is available on the shape of the obtained dose-response curve, and it is not known if a plateau of response is reached. We investigated this problem in 13 adult asthmatic subjects (PC20 methacholine results varying from 0.04 to 15.2 mg/ml), 5 normal and 2 former asthmatic individuals (PC20 greater than 8 mg/ml). Inhalation dose-response curves were drawn by asking the subjects to inhale dry cold air (-20 degrees C) for 3 min at progressively increasing degrees of ventilation (5, 10, 15, 20, etc., L/min) until maximal voluntary ventilation (MVV) or sufficient bronchoconstriction was reached. FEV1 was assessed after each degree until no further decline was seen. No functional recovery was observed before asking the subject to inhale the next dose of cold air. Maximal falls in FEV1 ranged from 20.7 to 56.5% in the current asthmatic subjects, whereas no significant (less than 10%) changes in FEV1 were obtained in the normal and former asthmatic individuals. Seven to 13 points on the individual dose-response curves were obtained for each current asthmatic subject. Curves were analyzed using the common pharmacologic logistic model. The coefficients of correlation were, in general, highly statistically significant. Curves obtained for the current asthmatic subjects represented a truncated sigmoidal pattern without a plateau. Curves were flat in the normal and former asthmatic individuals.(ABSTRACT TRUNCATED AT 250 WORDS)
在分钟通气量逐渐增加的情况下吸入冷空气,并在每次吸入之间评估支气管运动张力(剂量反应曲线),已被用作评估支气管高反应性的一种方法。然而,关于所获得的剂量反应曲线的形状尚无信息,也不清楚是否达到了反应平台期。我们在13名成年哮喘患者(乙酰甲胆碱激发试验的PC20结果在0.04至15.2 mg/ml之间)、5名正常人和2名既往有哮喘病史的个体(PC20大于8 mg/ml)中研究了这个问题。通过要求受试者在逐渐增加的通气程度(5、10、15、20等,L/min)下吸入干冷空气(-20℃)3分钟,直至达到最大自主通气量(MVV)或出现足够的支气管收缩,绘制吸入剂量反应曲线。在每个通气程度后评估第一秒用力呼气容积(FEV1),直至未见进一步下降。在要求受试者吸入下一剂冷空气之前,未观察到功能恢复。当前哮喘患者中FEV1的最大下降幅度为20.7%至56.5%,而正常人和既往有哮喘病史的个体中FEV1无显著(小于10%)变化。为每名当前哮喘患者在个体剂量反应曲线上获得7至13个点。使用常用的药理学逻辑模型分析曲线。相关性系数一般具有高度统计学意义。当前哮喘患者获得的曲线呈现出无平台的截断S形模式。正常人和既往有哮喘病史的个体的曲线是平坦的。(摘要截短至250字)